Updates

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Apr 20, 2021

Drug Company Banks Expectation-Busting Profits for Q1 While Continuing to Hike Read More

ICYMI: AMERICANS NEED RELIEF FROM BIG PHARMA’S OUT-OF-CONTROL PRESCRIPTION PRICES

Apr 19, 2021

Americans Need Relief from Big Pharma’s Out-of-Control Prescription Prices Read More

CSRXP: 117TH CONGRESS TAKES FIRST STEP ON LOWERING PRESCRIPTION DRUG PRICES, HOLDING BIG PHARMA ACCOUNTABLE

Apr 15, 2021

Lawmakers Pass Pair of Bills Aimed at Boosting Generic and Biosimilar Read More

DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR AMERICA’S CANCER PATIENTS

Apr 15, 2021

Drug Companies Repeatedly Hike Prices and Set Out-of-Control Launch Prices on Read More

SECOND OPINION: DEBUNKING BIG PHARMA’S NEW BRANDING CAMPAIGN

Apr 15, 2021

PhRMA Proposals Fail to Lower Rx Prices and Instead Benefit Drug Companies and Read More

CSRXP LAUNCHES CAMPAIGN ENCOURAGING POLICYMAKERS TO KEEP THEIR PROMISE TO LOWER RX PRICES

Apr 13, 2021

Campaign Will Highlight Impact of Out-of-Control Drug Prices, Especially in Read More

BOLDY BOGUS: CBO UNDERMINES BIG PHARMA’S INNOVATION RHETORIC

Apr 9, 2021

Government Report Finds No Relationship Between Drug Company R&D and Read More

THEY SAID IT! BIG PHARMA’S PRICE HIKES, PATENT THICKETS AND ADVERTISING SPENDING TAKE CENTER STAGE DURING SENATE HEARING

Mar 23, 2021

Lawmakers Make Bipartisan Commitment to Lowering Drug Prices, Holding Drug Read More

CSRXP APPLAUDS REINTRODUCTION OF FAIR DRUG PRICING ACT

Mar 23, 2021

Legislation Will Boost Transparency to Hold Big Pharma Accountable for Read More

CSRXP WELCOMES U.S. SENATE HEARING ON OUT-OF-CONTROL PRESCRIPTION DRUG PRICES

Mar 22, 2021

Lawmakers on HELP Subcommittee Can Add to Bipartisan Momentum to Hold Big Read More

CSRXP STATEMENT ON SENATE CONFIRMATION OF XAVIER BECERRA AS SECRETARY OF U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES

Mar 18, 2021

Campaign Looks Forward to Working with Secretary Becerra to Lower Drug Prices Read More

CSRXP: POLICYMAKERS SHOULD TAKE NOTICE AS PFIZER DOUBLES DOWN ON PLANS TO HIKE VACCINE PRICE

Mar 16, 2021

Big Pharma CFO Hypes “Significant Opportunity” From “Pricing Read More